I-Mab (NASDAQ: IMAB) is a U.S.-based, global biotech company, exclusively focused on the development and potential commercialization of highly differentiated immunotherapies for the treatment of cancer. I-Mab has established operations in the U.S. in Rockville, Maryland, and in San Diego, California.
View Top Employees from I-Mab BiopharmaWebsite | http://www.i-mabbiopharma.com/ |
Ticker | IMAB |
Revenue | $13.2 million |
Funding | $672 million |
Employees | 159 (158 on RocketReach) |
Founded | 2016 |
Address | 2440 Research Blvd Suite 400, Rockville, Maryland 20850, US |
Phone | +86 21 6057 8000 |
Technologies |
JavaScript,
HTML,
PHP
+27 more
(view full list)
|
Industry | Biotechnology, Pharmaceuticals, Biopharmaceutical, Healthcare, Antibody, Immuno-oncology , Immuno-inflammation, Oncology, Biologics, Pharmaceutical, Drug Development |
Keywords | Biologics, Healthcare, Pharmaceutical Manufacturing, Oncology, Biological Products, Therapeutic Activities, Biopharmaceuticals |
SIC | SIC Code 87 Companies, SIC Code 28 Companies, SIC Code 873 Companies, SIC Code 283 Companies |
NAICS | NAICS Code 54 Companies, NAICS Code 32 Companies, NAICS Code 325 Companies, NAICS Code 541 Companies |
Looking for a particular I-Mab Biopharma employee's phone or email?
The I-Mab Biopharma annual revenue was $13.2 million in 2024.
Jielun Zhu is the CFO of I-Mab Biopharma.
158 people are employed at I-Mab Biopharma.
I-Mab Biopharma is based in Rockville, Maryland.
The NAICS codes for I-Mab Biopharma are [54, 32, 325, 541].
The SIC codes for I-Mab Biopharma are [87, 28, 873, 283].